• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因果发现算法的挑战与机遇:在阿尔茨海默病病理生理学中的应用。

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology.

机构信息

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, 55455, USA.

Mayo Clinic, Rochester, MN, 55905, USA.

出版信息

Sci Rep. 2020 Feb 19;10(1):2975. doi: 10.1038/s41598-020-59669-x.

DOI:10.1038/s41598-020-59669-x
PMID:32076020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7031278/
Abstract

Causal Structure Discovery (CSD) is the problem of identifying causal relationships from large quantities of data through computational methods. With the limited ability of traditional association-based computational methods to discover causal relationships, CSD methodologies are gaining popularity. The goal of the study was to systematically examine whether (i) CSD methods can discover the known causal relationships from observational clinical data and (ii) to offer guidance to accurately discover known causal relationships. We used Alzheimer's disease (AD), a complex progressive disease, as a model because the well-established evidence provides a "gold-standard" causal graph for evaluation. We evaluated two CSD methods, Fast Causal Inference (FCI) and Fast Greedy Equivalence Search (FGES) in their ability to discover this structure from data collected by the Alzheimer's Disease Neuroimaging Initiative (ADNI). We used structural equation models (which is not designed for CSD) as control. We applied these methods under three scenarios defined by increasing amounts of background knowledge provided to the methods. The methods were evaluated by comparing the resulting causal relationships with the "gold standard" graph that was constructed from literature. Dedicated CSD methods managed to discover graphs that nearly coincided with the gold standard. For best results, CSD algorithms should be used with longitudinal data providing as much prior knowledge as possible.

摘要

因果结构发现(CSD)是通过计算方法从大量数据中识别因果关系的问题。由于传统基于关联的计算方法发现因果关系的能力有限,CSD 方法越来越受欢迎。本研究的目的是系统地检查(i)CSD 方法是否可以从观察性临床数据中发现已知的因果关系,以及(ii)提供准确发现已知因果关系的指导。我们使用阿尔茨海默病(AD)作为模型,因为已建立的证据为评估提供了一个“黄金标准”因果图。我们评估了两种 CSD 方法,即快速因果推理(FCI)和快速贪婪等价搜索(FGES),以了解它们从阿尔茨海默病神经影像学倡议(ADNI)收集的数据中发现这种结构的能力。我们使用结构方程模型(不是为 CSD 设计的)作为对照。我们在三种情况下应用这些方法,这些情况由向方法提供的背景知识的数量来定义。通过将得到的因果关系与从文献中构建的“黄金标准”图进行比较来评估这些方法。专门的 CSD 方法设法发现了与黄金标准几乎一致的图。为了获得最佳结果,应使用提供尽可能多先验知识的纵向数据来使用 CSD 算法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/6ca38190ae2f/41598_2020_59669_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/1e7cdfc5c53c/41598_2020_59669_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/a3b04cc9f94c/41598_2020_59669_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/d3963403195a/41598_2020_59669_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/e021cae3cad1/41598_2020_59669_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/6ca38190ae2f/41598_2020_59669_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/1e7cdfc5c53c/41598_2020_59669_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/a3b04cc9f94c/41598_2020_59669_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/d3963403195a/41598_2020_59669_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/e021cae3cad1/41598_2020_59669_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b8/7031278/6ca38190ae2f/41598_2020_59669_Fig5_HTML.jpg

相似文献

1
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology.因果发现算法的挑战与机遇:在阿尔茨海默病病理生理学中的应用。
Sci Rep. 2020 Feb 19;10(1):2975. doi: 10.1038/s41598-020-59669-x.
2
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
3
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.载脂蛋白 E 对阿尔茨海默病淀粉样蛋白负荷和神经元病理学生物标志物的影响。
Ann Neurol. 2010 Mar;67(3):308-16. doi: 10.1002/ana.21953.
4
Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.载脂蛋白 E ε4 和 ε3 等位基因与轻度认知障碍患者的脑脊液 tau 和认知相关,但与阿尔茨海默病患者无关,且与淀粉样蛋白-β相关。
J Integr Neurosci. 2021 Jun 30;20(2):277-286. doi: 10.31083/j.jin2002027.
5
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性:与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
6
Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.载脂蛋白 E ε4 与内侧颞叶 tau 相关,与淀粉样蛋白-β无关。
JAMA Neurol. 2020 Apr 1;77(4):470-479. doi: 10.1001/jamaneurol.2019.4421.
7
Alzheimer's: forestalling the darkness.阿尔茨海默病:延缓黑暗降临。
Sci Am. 2010 Jun;302(6):50-7. doi: 10.1038/scientificamerican0610-50.
8
Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.基底前脑萎缩与阿尔茨海默病中的β淀粉样蛋白负荷相关。
Neuroimage Clin. 2014 Nov 27;7:105-13. doi: 10.1016/j.nicl.2014.11.015. eCollection 2015.
9
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.
10
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

引用本文的文献

1
Causal Discovery Analysis Reveals Insights into Psychosis Proneness, Brain Function, and Environmental Factors among Young Individuals.因果发现分析揭示了年轻人中精神病易感性、脑功能和环境因素之间的关联。
Psychiatry Res Neuroimaging. 2025 Aug;351:112015. doi: 10.1016/j.pscychresns.2025.112015. Epub 2025 Jun 8.
2
Investigating causal networks of dementia using causal discovery and natural language processing models.使用因果发现和自然语言处理模型研究痴呆症的因果网络。
NPJ Dement. 2025;1(1):4. doi: 10.1038/s44400-025-00006-2. Epub 2025 May 9.
3
Contribution of Structure Learning Algorithms in Social Epidemiology: Application to Real-World Data.

本文引用的文献

1
Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.临床前阿尔茨海默病的纵向脑成像:APOE ε4 基因型的影响。
Brain. 2018 Jun 1;141(6):1828-1839. doi: 10.1093/brain/awy103.
2
Big Data and Machine Learning in Health Care.医疗保健中的大数据与机器学习
JAMA. 2018 Apr 3;319(13):1317-1318. doi: 10.1001/jama.2017.18391.
3
Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.老年样本中的年龄、血管健康与阿尔茨海默病生物标志物
结构学习算法在社会流行病学中的贡献:对真实世界数据的应用
Int J Environ Res Public Health. 2025 Feb 27;22(3):348. doi: 10.3390/ijerph22030348.
4
DAGAF: A directed acyclic generative adversarial framework for joint structure learning and tabular data synthesis.DAGAF:用于联合结构学习和表格数据合成的有向无环生成对抗框架。
Appl Intell (Dordr). 2025;55(7):602. doi: 10.1007/s10489-025-06410-8. Epub 2025 Mar 31.
5
Utilising causal inference methods to estimate effects and strategise interventions in observational health data.利用因果推断方法来估计观察性健康数据中的效应并制定干预策略。
PLoS One. 2024 Dec 30;19(12):e0314761. doi: 10.1371/journal.pone.0314761. eCollection 2024.
6
Identifying causal neural oscillations underlying working memory.识别工作记忆背后的因果神经振荡。
Cereb Cortex. 2025 Feb 5;35(2). doi: 10.1093/cercor/bhae492.
7
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia.探究精神分裂症患者精神病理变量、认知障碍和现实生活功能之间的因果路径。
Schizophrenia (Heidelb). 2025 Jan 3;11(1):1. doi: 10.1038/s41537-024-00545-2.
8
The Transition From Homogeneous to Heterogeneous Machine Learning in Neuropsychiatric Research.神经精神医学研究中从同质机器学习到异质机器学习的转变
Biol Psychiatry Glob Open Sci. 2024 Sep 26;5(1):100397. doi: 10.1016/j.bpsgos.2024.100397. eCollection 2025 Jan.
9
Mixed-variable graphical modeling framework towards risk prediction of hospital-acquired pressure injury in spinal cord injury individuals.混合变量图形建模框架,用于预测脊髓损伤患者的医院获得性压疮风险。
Sci Rep. 2024 Oct 23;14(1):25067. doi: 10.1038/s41598-024-75691-9.
10
Can algorithms replace expert knowledge for causal inference? A case study on novice use of causal discovery.算法能否取代专家知识进行因果推断?一项关于新手使用因果发现的案例研究。
Am J Epidemiol. 2025 May 7;194(5):1399-1409. doi: 10.1093/aje/kwae338.
Ann Neurol. 2017 Nov;82(5):706-718. doi: 10.1002/ana.25071. Epub 2017 Oct 26.
4
Will Machine Learning Tip the Balance in Breast Cancer Screening?机器学习会改变乳腺癌筛查的平衡吗?
JAMA Oncol. 2017 Nov 1;3(11):1463-1464. doi: 10.1001/jamaoncol.2017.0473.
5
Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.年龄、性别和APOE ε4对成年期记忆、脑结构及β淀粉样蛋白的影响。
JAMA Neurol. 2015 May;72(5):511-9. doi: 10.1001/jamaneurol.2014.4821.
6
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.ADNI 认知正常受试者的神经元损伤生物标志物与预后。
Acta Neuropathol Commun. 2014 Mar 6;2:26. doi: 10.1186/2051-5960-2-26.
7
The inevitable application of big data to health care.大数据在医疗保健领域的必然应用。
JAMA. 2013 Apr 3;309(13):1351-2. doi: 10.1001/jama.2013.393.
8
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.阿尔茨海默病病理生理过程的追踪:动态生物标志物的更新假设模型。
Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.
9
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.AD 和 MCI 认知、功能和 FDG-PET 测量下降之间的关联。
Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5.
10
Diabetes is related to cerebral infarction but not to AD pathology in older persons.糖尿病与老年人的脑梗死有关,但与阿尔茨海默病病理无关。
Neurology. 2006 Dec 12;67(11):1960-5. doi: 10.1212/01.wnl.0000247053.45483.4e.